Τίτλος:
Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
The novel coronavirus SARS-CoV-2 has emerged as a severe threat against public health and global economies. COVID-19, the disease caused by this virus, is highly contagious and has led to an ongoing pandemic. SARS-CoV-2 affects, mainly, the respiratory system, with most severe cases primarily showcasing acute respiratory distress syndrome. Currently, no targeted therapy exists, and since the number of infections and death toll keeps rising, it has become a necessity to study possible therapeutic targets. Antiviral drugs can target various stages of the viral infection, and in the case of SARS-CoV-2, both structural and non-structural proteins have been proposed as potential drug targets. This review focuses on the most researched SARS-CoV-2 proteins, their structure, function, and possible therapeutic approaches. © 2020 Elsevier Ltd
Συγγραφείς:
Vlachakis, D.
Papakonstantinou, E.
Mitsis, T.
Pierouli, K.
Diakou, I.
Chrousos, G.
Bacopoulou, F.
Περιοδικό:
Food and Chemical Toxicology
Εκδότης:
Elsevier Ireland Ltd
Λέξεις-κλειδιά:
envelope protein; helicase; membrane protein; nucleocapsid protein; proteinase; virus spike protein; antivirus agent; viral protein, Article; coronavirus disease 2019; drug targeting; human; nonhuman; pandemic; protein function; protein structure; protein targeting; Severe acute respiratory syndrome coronavirus 2; drug therapy; epidemic; metabolism; pandemic; pathogenicity; virology, Antiviral Agents; COVID-19; Disease Outbreaks; Humans; Pandemics; SARS-CoV-2; Viral Proteins
DOI:
10.1016/j.fct.2020.111805
